Crescent Biopharma, Inc. (CBIO)
11.85
-0.37
(-3.03%)
USD |
NASDAQ |
Dec 19, 16:00
11.88
+0.03
(+0.25%)
After-Hours: 20:00
Crescent Biopharma Total Liabilities (Quarterly): 21.63M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| XOMA Royalty Corp. | 155.19M |
| Viridian Therapeutics, Inc. | 74.17M |
| DiaMedica Therapeutics, Inc. | 5.425M |
| Denali Therapeutics, Inc. | 129.42M |
| Praxis Precision Medicines, Inc. | 52.88M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 138.27M |
| Shareholders Equity (Quarterly) | 116.64M |
| Debt to Equity Ratio | 0.0149 |
| Current Ratio | 6.627 |
| Net Debt Paydown Yield | -0.16% |